Marker Therapeutics terminates ATM equity facility; shareholders elect board, approve auditor and pay

Marker Therapeutics, Inc.

Shareholders elected five directors: D. Eansor, S. Elms, J. Wilson, J. Vera, K. Knobil; each with >3M votes for.
Advisory 'say-on-pay' vote passed 2,931,920 for vs 276,480 against, with 14,000 abstentions.
Ratification of Marcum LLP as auditor for FY2024 passed 5,137,819 for vs 494,128 against, with 14,366 abstentions.
Terminated ATM equity facility with Cantor Fitzgerald & Co. and RBC Capital Markets; facility allowed up to $75M in stock sales, no termination penalties.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.